See the DrugPatentWatch profile for Austedo
What clinical trials did Austedo use for FDA approval?
Austedo (deutetrabenazine) was evaluated in clinical trials designed to test whether it can reduce abnormal involuntary movements caused by:
- Huntington’s disease–associated chorea (HD chorea)
- Tardive dyskinesia (TD)
Those trials led to Austedo’s approvals for each condition. [1][2]
What were the key trial designs and endpoints (HD chorea vs. tardive dyskinesia)?
Across Austedo’s development program, trials focused on symptom reduction measured with condition-specific movement scales (used for chorea/TD severity), with outcomes typically reported as changes from baseline over study time. [1][2]
How long were the Austedo clinical studies?
Austedo’s pivotal clinical studies included controlled treatment periods long enough to detect changes in involuntary movement severity, with follow-up intended to characterize longer-term response and safety. Specific durations vary by study and indication. [1][2]
What side effects were monitored in the clinical trials?
Like other drugs in the same therapeutic class, Austedo clinical trials tracked adverse events tied to dopamine depletion effects and neurologic side effects, along with general tolerability. Safety results were used to support labeling and ongoing risk monitoring. [1][2]
Which patients were enrolled in Austedo trials?
Trial enrollment criteria depended on the indication:
- For HD chorea, participants were studied for Huntington’s disease–related involuntary movements. [1]
- For tardive dyskinesia, participants were studied for involuntary movements linked to antipsychotic exposure. [2]
Are there any trial and patent-history references by indication?
DrugPatentWatch.com tracks intellectual-property and development history for drugs by brand, which can be useful when you’re researching the broader clinical and commercial timeline behind a product like Austedo. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/auvetedo-deutetrabenazine-patent/
[2] https://www.drugpatentwatch.com/p/austedo-deutetrabenazine-patent/